Literature DB >> 28624976

Are Concerns About Irremediableness, Vulnerability, or Competence Sufficient to Justify Excluding All Psychiatric Patients from Medical Aid in Dying?

William Rooney1, Udo Schuklenk2, Suzanne van de Vathorst3,4.   

Abstract

Some jurisdictions that have decriminalized assisted dying (like Canada) exclude psychiatric patients on the grounds that their condition cannot be determined to be irremediable, that they are vulnerable and in need of protection, or that they cannot be determined to be competent. We review each of these claims and find that none have been sufficiently well-supported to justify the differential treatment psychiatric patients experience with respect to assisted dying. We find bans on psychiatric patients' access to this service amount to arbitrary discrimination. Proponents of banning the practice ignore or overlook alternatives to their proposal, like an assisted dying regime with additional safeguards. Some authors have further criticized assisted dying for psychiatric patients by highlighting allegedly problematic practices in those countries which allow it. We address recent evidence from the Netherlands, showing that these problems are either misrepresented or have straightforward solutions. Even if one finds such evidence troubling despite our analysis, other jurisdictions need not adopt every feature of the Dutch system.

Entities:  

Keywords:  Competence assessment; Decisional capacity; Depression; Euthanasia; Irremediable; Medical assistance in dying; Physician assisted suicide; Vulnerable

Mesh:

Year:  2018        PMID: 28624976     DOI: 10.1007/s10728-017-0344-8

Source DB:  PubMed          Journal:  Health Care Anal        ISSN: 1065-3058


  24 in total

1.  How stigma interferes with mental health care.

Authors:  Patrick Corrigan
Journal:  Am Psychol       Date:  2004-10

Review 2.  Treatment-resistant major depressive disorder and assisted dying.

Authors:  Udo Schuklenk; Suzanne van de Vathorst
Journal:  J Med Ethics       Date:  2015-05-02       Impact factor: 2.903

Review 3.  Medical assistance in dying: special issues for patients with mental illness.

Authors:  Kathleen Sheehan; K Sonu Gaind; James Downar
Journal:  Curr Opin Psychiatry       Date:  2017-01       Impact factor: 4.741

Review 4.  Four Reasons Why Assisted Dying Should Not Be Offered for Depression.

Authors:  Thomas Blikshavn; Tonje Lossius Husum; Morten Magelssen
Journal:  J Bioeth Inq       Date:  2016-12-08       Impact factor: 1.352

5.  Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan W Stewart; Diane Warden; George Niederehe; Michael E Thase; Philip W Lavori; Barry D Lebowitz; Patrick J McGrath; Jerrold F Rosenbaum; Harold A Sackeim; David J Kupfer; James Luther; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

6.  The Maudsley Staging Method for treatment-resistant depression: prediction of longer-term outcome and persistence of symptoms.

Authors:  Abebaw Fekadu; Sarah C Wooderson; Kalypso Markopoulou; Anthony J Cleare
Journal:  J Clin Psychiatry       Date:  2009-05-19       Impact factor: 4.384

7.  Prediction of longer-term outcome of treatment-resistant depression in tertiary care.

Authors:  Abebaw Fekadu; Lena J Rane; Sarah C Wooderson; Kalypso Markopoulou; Lucia Poon; Anthony J Cleare
Journal:  Br J Psychiatry       Date:  2012-09-06       Impact factor: 9.319

Review 8.  What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies.

Authors:  Abebaw Fekadu; Sarah C Wooderson; Kalypso Markopoulo; Catherine Donaldson; Andrew Papadopoulos; Anthony J Cleare
Journal:  J Affect Disord       Date:  2008-11-12       Impact factor: 4.839

9.  Euthanasia requests, procedures and outcomes for 100 Belgian patients suffering from psychiatric disorders: a retrospective, descriptive study.

Authors:  Lieve Thienpont; Monica Verhofstadt; Tony Van Loon; Wim Distelmans; Kurt Audenaert; Peter P De Deyn
Journal:  BMJ Open       Date:  2015-07-27       Impact factor: 2.692

10.  Bereavement after the suicide of a significant other.

Authors:  Maurizio Pompili; Amresh Shrivastava; Gianluca Serafini; Marco Innamorati; Mariantonietta Milelli; Denise Erbuto; Federica Ricci; Dorian A Lamis; Paolo Scocco; Mario Amore; David Lester; Paolo Girardi
Journal:  Indian J Psychiatry       Date:  2013-07       Impact factor: 1.759

View more
  6 in total

1.  Physician Assisted Death for Psychiatric Suffering: Experiences in the Netherlands.

Authors:  Smp van Veen; Gam Widdershoven; Atf Beekman; N Evans
Journal:  Front Psychiatry       Date:  2022-06-20       Impact factor: 5.435

2.  "For Their Own Good": A Response to Popular Arguments Against Permitting Medical Assistance in Dying (MAID) where Mental Illness Is the Sole Underlying Condition.

Authors:  Justine Dembo; Udo Schuklenk; Jonathan Reggler
Journal:  Can J Psychiatry       Date:  2018-04-10       Impact factor: 4.356

3.  Too much safety? Safeguards and equal access in the context of voluntary assisted dying legislation.

Authors:  Rosalind McDougall; Bridget Pratt
Journal:  BMC Med Ethics       Date:  2020-05-13       Impact factor: 2.652

4.  Terminal anorexia nervosa: three cases and proposed clinical characteristics.

Authors:  Jennifer L Gaudiani; Alyssa Bogetz; Joel Yager
Journal:  J Eat Disord       Date:  2022-02-15

5.  Feeling Seen, Being Heard: Perspectives of Patients Suffering from Mental Illness on the Possibility of Physician-Assisted Death in the Netherlands.

Authors:  Rosalie Pronk; Dick L Willems; Suzanne van de Vathorst
Journal:  Cult Med Psychiatry       Date:  2021-06-16

6.  Experiences and views of Dutch general practitioners regarding physician-assisted death for patients suffering from severe mental illness: a mixed methods approach.

Authors:  Rosalie Pronk; Nieke P Sindram; S van de Vathorst; D L Willems
Journal:  Scand J Prim Health Care       Date:  2021-07-09       Impact factor: 2.581

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.